Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-124061
Filing Date
2025-12-19
Accepted
2025-12-19 21:25:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13698
2 AGREEMENT OF JOINT FILING ea027028001ex-a_azitra.htm EX-99.A 4881
  Complete submission text file 0001213900-25-124061.txt   20344
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Subject) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94105 | Film No.: 251589097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 405 LEXINGTON AVE. 9TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVE. 9TH FLOOR NEW YORK NY 10174 (818) 438-9794
Alumni Capital LP (Filed by) CIK: 0001912606 (see all company filings)

EIN.: 873893017 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A